tetraethylammonium has been researched along with Ataxia in 2 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
Excerpt | Relevance | Reference |
---|---|---|
"Episodic ataxia type 1 (EA-1) is a rare neurological disorder and was the first ionic channel disease to be associated with defects in a potassium channel." | 1.30 | Expression in mammalian cells and electrophysiological characterization of two mutant Kv1.1 channels causing episodic ataxia type 1 (EA-1). ( Bretschneider, F; Grissmer, S; Lehmann-Horn, F; Wrisch, A, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zerr, P | 1 |
Adelman, JP | 1 |
Maylie, J | 1 |
Bretschneider, F | 1 |
Wrisch, A | 1 |
Lehmann-Horn, F | 1 |
Grissmer, S | 1 |
2 other studies available for tetraethylammonium and Ataxia
Article | Year |
---|---|
Episodic ataxia mutations in Kv1.1 alter potassium channel function by dominant negative effects or haploinsufficiency.
Topics: Animals; Ataxia; Electric Stimulation; Electrophysiology; Female; Gene Expression; Haplotypes; Human | 1998 |
Expression in mammalian cells and electrophysiological characterization of two mutant Kv1.1 channels causing episodic ataxia type 1 (EA-1).
Topics: Acetazolamide; Animals; Ataxia; Electric Conductivity; Electrophysiology; Kv1.1 Potassium Channel; M | 1999 |